Mycosis fungoides and Sézary syndrome following dupilumab treatment: experience of two Italian tertiary care centres

Dupilumab is a monoclonal antibody targeting the interleukin-4 and -13 signalling pathway, and which is proven to be highly effective and safe in atopic dermatitis (AD). Its possible role in treating or inducing cutaneous T-cell lymphomas (CTCLs) has not yet been fully clarified, as several case rep...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical and experimental dermatology 2023-11, Vol.48 (12), p.1376-1378
Hauptverfasser:	Buffon, Stefano, Alberti Violetti, Silvia, Avallone, Gianluca, Venegoni, Luigia, Marzano, Angelo V, Mastorino, Luca, Fava, Paolo, Ribero, Simone, Quaglino, Pietro, Ortoncelli, Michela, Ferrucci, Silvia M
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!